Advertisement
UK markets open in 5 hours 9 minutes

  • NIKKEI 225

    37,844.10
    -117.70 (-0.31%)
     

  • HANG SENG

    16,240.46
    -11.38 (-0.07%)
     

  • CRUDE OIL

    82.69
    0.00 (0.00%)
     

  • GOLD FUTURES

    2,382.20
    -6.20 (-0.26%)
     

  • DOW

    37,753.31
    -45.66 (-0.12%)
     

  • Bitcoin GBP

    49,438.43
    -1,881.89 (-3.67%)
     

  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     

  • NASDAQ Composite

    15,683.37
    -181.88 (-1.15%)
     

  • UK FTSE All Share

    4,273.02
    +12.61 (+0.30%)
     
Money:

5 ways to get help with childcare costs

Childcare is eye-wateringly expensive, here are some ways to save money

Orphan Drugs Among 2015's Top 10 Best-Selling Medications

Jayson Derrick

Orphan drugs, drugs intended to prevent, diagnose or treat rare diseases/disorders, are huge sellers for the pharmaceutical industry.

NPR, citing data from EvaluatePharma, noted that seven of the 10 best-selling drugs in the United States throughout 2015 were given an orphan drug status. The main issue at hand is that some of the drugs are not true orphans in the sense that they were first approved for the mass market but later won approval for the treatment of a rare disease.

For example, AbbVie Inc (NYSE: ABBV)'s Humira was granted orphan drug designation for moderate to severe HS (Hurley Stage II and Hurley Stage III disease), yet the same therapy can be used for the treatment of many other conditions, including rheumatoid arthritis.

ADVERTISEMENT

Best-Selling Drugs

Nevertheless, here is a list of the top 10 best-selling drugs in 2015, with orphan drugs asterisked:

See more from Benzinga

© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.